CC
KRTX

Casdin Capital’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Casdin Capital’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-85,000
Closed -$10.8M – 44
2022
Q2 		$10.8M Buy
+85,000
New +$10.8M 0.91% 24